CYBN Conference

Cybin to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Published September 04, 2025 at 11:30 AM

(CYBN) TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced that George Tziras, Cybin’s Chief Business Officer, will participate in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference on Monday, September 8, 2025, at 11:00 a.m. ET. The webcast a